(Q35450779)
Statements
Efficacy, safety, and tolerance of the non-ergoline dopamine agonist pramipexole in the treatment of advanced Parkinson's disease: a double blind, placebo controlled, randomised, multicentre study (English)
O Pogarell
1 April 1999
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference